This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1229
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Sandbox_Reserved_Jason_Telford}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_Jason_Telford}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
| - | == | + | ==Structure== |
| - | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene='<scene name='75/750278/Rituximab_structure_bh/3'> | + | <StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene='<scene name='75/750278/Rituximab_structure_bh/3'>Rituximab is a genetically engineered chimeric murine and human monoclonal antibody. It is of the IgG class, specifically an IgG kappa immunoglobulin containing murine light and heavy-chain variable region sequences and human constant region sequences. Rituximab's two heavy chains are 451 amino acids long and its two light chains are 213 amino acids long. It's chemical formula is C6416H9874N1688O1987S44, and the average weight of this large protein is 143,850.7 Da. |
| - | + | ||
| - | + | ||
== Function == | == Function == | ||
Revision as of 02:03, 4 May 2017
| This Sandbox is Reserved from Jan 17 through June 31, 2017 for use in the course Biochemistry II taught by Jason Telford at the Maryville University, St. Louis, USA. This reservation includes Sandbox Reserved 1225 through Sandbox Reserved 1244. |
To get started:
More help: Help:Editing |
Structure
| |||||||||||
